MARKET

NRXS

NRXS

Neuraxis Inc
AMEX
6.80
+0.13
+1.95%
After Hours: 7.07 +0.27 +3.93% 16:51 06/09 EDT
OPEN
6.67
PREV CLOSE
6.67
HIGH
6.96
LOW
6.38
VOLUME
131.76K
TURNOVER
--
52 WEEK HIGH
9.33
52 WEEK LOW
2.196
MARKET CAP
84.21M
P/E (TTM)
-8.3436
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NRXS last week (0601-0605)?
Weekly Report · 1d ago
Weekly Report: what happened at NRXS last week (0525-0529)?
Weekly Report · 06/01 10:14
Weekly Report: what happened at NRXS last week (0518-0522)?
Weekly Report · 05/25 10:17
NeurAxis Earnings Call Highlights Growth and Hurdles
TipRanks · 05/20 08:34
Weekly Report: what happened at NRXS last week (0511-0515)?
Weekly Report · 05/18 10:17
NeurAxis Stock Gains Post Q1 Earnings, Revenues and Margin Surge Y/Y
NASDAQ · 05/15 16:23
NeurAxis signals burn rate of $1M or less for rest of 2026 while targeting ~ $15M revenue for cash flow breakeven
Seeking Alpha · 05/12 20:42
Craig-Hallum Sticks to Its Buy Rating for NeurAxis, Inc. (NRXS)
TipRanks · 05/12 20:37
More
About NRXS
Neuraxis, Inc. is a medical technology company. The Company is focused on developing neuromodulation therapies for chronic and debilitating conditions in gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults. Its IB-Stim, is a Percutaneous Electrical Nerve Field Stimulation (PENFS) technology intended to be used in patients eight years and older with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. Its second product, RED (Rectal Expulsion Device), is indicated to evaluate the neuromuscular function of a patient’s ability to expel its contents from the rectum and as a qualitative test for rectal hypersensitivity. RED (K242304, 2024) helps identify patients with rectal hypersensitivity who experience a desire or urge to defecate at lower volumes of distension.

Webull offers Neuraxis Inc stock information, including AMEX: NRXS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NRXS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NRXS stock methods without spending real money on the virtual paper trading platform.